United Income Inc. purchased a new stake in shares of Danaher Co. (NYSE:DHR) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,321 shares of the conglomerate’s stock, valued at approximately $1,786,000.
A number of other hedge funds have also recently added to or reduced their stakes in the business. FMR LLC lifted its stake in shares of Danaher by 10.3% in the second quarter. FMR LLC now owns 21,011,026 shares of the conglomerate’s stock valued at $2,073,369,000 after buying an additional 1,963,116 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Danaher by 87.4% in the third quarter. Renaissance Technologies LLC now owns 3,219,500 shares of the conglomerate’s stock valued at $349,831,000 after buying an additional 1,501,300 shares during the period. AQR Capital Management LLC lifted its stake in shares of Danaher by 48.2% in the third quarter. AQR Capital Management LLC now owns 2,682,662 shares of the conglomerate’s stock valued at $291,498,000 after buying an additional 872,626 shares during the period. Vanguard Group Inc lifted its stake in shares of Danaher by 1.4% in the third quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock valued at $4,861,338,000 after buying an additional 605,018 shares during the period. Finally, Bank of Montreal Can lifted its stake in shares of Danaher by 113.3% in the third quarter. Bank of Montreal Can now owns 1,069,328 shares of the conglomerate’s stock valued at $116,195,000 after buying an additional 567,990 shares during the period. Institutional investors own 77.05% of the company’s stock.
NYSE:DHR opened at $109.25 on Friday. Danaher Co. has a 12-month low of $91.84 and a 12-month high of $111.10. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.47 and a quick ratio of 1.07. The stock has a market capitalization of $76.11 billion, a P/E ratio of 24.17, a price-to-earnings-growth ratio of 2.00 and a beta of 0.99.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The firm had revenue of $5.40 billion during the quarter, compared to analyst estimates of $5.33 billion. During the same quarter in the prior year, the business posted $1.19 earnings per share. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Equities analysts predict that Danaher Co. will post 4.78 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, January 25th. Investors of record on Friday, December 28th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.59%. The ex-dividend date of this dividend was Thursday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 14.16%.
Several equities research analysts recently weighed in on DHR shares. Royal Bank of Canada reiterated a “hold” rating and issued a $102.00 target price on shares of Danaher in a research note on Wednesday, December 19th. Needham & Company LLC started coverage on shares of Danaher in a research note on Wednesday, January 2nd. They issued a “buy” rating and a $114.00 target price for the company. Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Friday, October 12th. Cowen reiterated a “buy” rating and issued a $110.00 target price on shares of Danaher in a research note on Monday, January 7th. Finally, Robert W. Baird reduced their target price on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research note on Friday, October 19th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $113.08.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More: Book Value Per Share – BVPS
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.